Loading chat...
NY A10668
Bill
Status
7/22/2024
Primary Sponsor
Philip Ramos
Click for details
AI Summary
-
Requires pharmacists to obtain express written consent from patients before substituting a prescribed drug product for a less expensive generic or alternative drug product with the same active ingredients, dosage form, and strength.
-
Applies the express written consent requirement to out-of-state dispensers when patients choose to have prescriptions filled outside New York.
-
Extends the consent requirement to biological product substitutions, requiring patients to authorize pharmacists to substitute prescribed biological products for less expensive interchangeable biological products.
-
Takes effect ninety days after the bill becomes law, with regulatory agencies authorized to implement necessary rules immediately upon enactment.
Legislative Description
Requires that pharmacists get express written consent before substituting a drug product for a less expensive drug product, including biological products.
Last Action
referred to higher education
7/22/2024